Vertex to participate in upcoming investor conferences

Boston--(business wire)--vertex pharmaceuticals incorporated (nasdaq: vrtx) today announced management participation in three upcoming investor conferences. susie lisa, senior vice president, investor relations, and manisha pai, executive director, investor relations, will participate in the evercore biotechnology summit on wednesday, may 21, 2025. dr. reshma kewalramani, chief executive officer and president, will participate in a fireside chat at the bernstein 41st annual strategic decisions.
VRTX Ratings Summary
VRTX Quant Ranking